sample size and final volume of leukocyte extract vary with the enzyme to be assayed. For example, carbamylphosphate syntheenzymes the urea cycle are demonstrable in circulating tases (CPS I and 11) were usually done on 30-45-m) blood samples leukocytes. They show the same relative activities as those in liver and homogenized in a final extract volume of 6.3 ml, except for argininosuccinate synthetase + lyase (combined) which
ORNITHINE TRANSCARBAMYLASE
have measurable activity of all the enzymes in the cycle.
The assay system consisted of L-ornithine, pH 8.0, 10 m M ; N a METHODS AND MATERIALS glycylglycine buffer, pH 8.3, 45 m M ; dilithium carbamylphosphate, 10 mM; and leukocyte extract (0.10 ml) in a final volume of Commercial reagents were used except for ornithine transcar-0.30 ml. Incubation was for 1 hr. For the blank tubes the enzyme bamylase (OTC) which was prepared from bovine liver according was inactivated by boiling the extract or by the addition of 0.050 to the method of Marshall and Cohen (8) . Fresh bovine liver (1. 2 freshly made mercuric acetate (0,015 M) (16) before the kg) was used for the preparation. The procedure followed steps 1 incubation because the nonenzymatic condensation of carbamylthrough 6 with a recovery of 30%. This preparation yielded a phosphate and ornithine which contributes to the blank is pH volume of 10 mi with an activity of 14.500 units/ml (mi~r0m0leS of dependent. Perchloric acid addition before the incubation would citrulline formed per hour).
give a falsely low control. After the incubation 0.10 ml 2 M he leukocytes were prepared according to the method of perchloric acid was added to all tubes to stop the reaction and Suzuki (17) with minor modifications. Five volumes of freshly mercuric acetate was added to the reaction tubes to maintain drawn blood was mixed rapidly with I volume of a solution of 5% identity with the blanks, Carbamylphosphate was made up freshly dextran, 0.7% NaCI, and 0.05% heparin. After the white cell layer before each use, The tubes were centrifuged and 0.10 ml supernahad settled for 45 min at room temperature, it was removed and tant was used for color production, centrifuged at 600 x g at 3". The resulting pellet underwent two isotonic saline washes with recovery by centrifuging at 4,000 x g a t
ARGININOSUCCINATE SYNTHETASE A N D LYASE SYSTEM
3" and then was mixed gently into 5 mi distilled water for 60 sec to remove red blood cells. Five milliliters of 1.7% NaCl were added
The assay system consisted of magnesium sulfate, 5 mM; ATP, and the pellet was recovered by centrifuging at 4,000 x g at 3". pH 7.0, 5 mM; L-citrulline, pH 7.0, 5 mM; L-aspartate, pH 7.0, 5 This final pellet was homogenized in distilled water, frozen and mM; potassium phosphate buffer, pH 7.0, 50 mM; arginase thawed three times, and centrifuged at 12,000 x g for 5 min. The (ARC) 20 units (measured in micromoles of urea formed per clear supernatant was used for triplicate assays. The starting blood hour), Sigma Chemical Co., and leukocyte extract (0.50 ml) in a final volume of 0.620 ml. The first five reagents were added together in a volume of 0.10 ml to start the reaction. After 1 hr at 37" all tubes received 0.10 ml 2 M perchloric acid except the blanks which had the perchloric acid added before incubation. The tubes were centrifuged and 0.50 ml supernatant was used for urea determination. Standards contained citrulline as in the blanks and samples. Inasmuch as less than 2% of the substrate was used, no compensation for citrulline effect on the urea chromogen was applied.
The assay system consisted of L-arginine, pH 9.5, 12.5 mM; MnCI,, 0.25 mM; sodium glycinate buffer, pH 9.5, 25 m M ; and leukocyte extract (0.10 ml) in a final volume of 0.30 ml. Incubation was for 30 min at 37'. Blanks received 0.10 ml 2 M perchloric acid before the incubation, whereas the reaction tubes received the perchloric acid after the incubation. The tubes were centrifuged and 0.10 ml supernatant was used for color production. standards contained arginine as in the blanks and samples. Because less than 3% of the substrate was used, no compensation for arginine effect on the urea chromogen was applied.
Color Production. The clear supernatant solutions were analyzed for either citrulline or urea according to the procedure of Archibald ( I , 2) as modified by Ratner (13) except for the volume and dilution changes outlined in Table 1 . The supernatants and chromogens were transferred to screw top tubes and boiled; ( I ) for 40 min in the case of the citrulline-producing assays and (2) for 60 min for the urea-producing assays. Because of the light sensitivity of the products formed, the tubes were boiled and cooled in the dark. Optical densities were read on a Zeiss P M Q I1 spectrophotometer. Average optical densities obtained are shown in Table 2 . Protein was determined by the method of Lowry rt al. (7).
RESULTS
Activities were linear with respect to both time ( Fig. 1 ) and protein concentration (Fig. 2 ) over the ranges used in these assays. The normal values found for the leukocyte urea cycle enzymes are shown in Table 3 .
The leukocyte enzymes, although much less active than those in liver, show the same relative activity pattern except for ASS + L.
In comparison with autopsy controls ( T o see whether the leukocyte assays reflect liver enzyme deficiency, blood from patients with three hepatic urea cycle enzyme disorders was tested (Table 4) . Patient I , as described by McMurray et al. (9) , has been shown to have a liver argininosuccinate synthetase deficiency with activity only 5% of liver biopsy controls. Patient 2 (19) has the clinical and (15) . Patient 3 is one of a small group of related patients with high blood N H , , ornithine, and urine homocitrulline. Needle biopsy of liver indicated his C P S I activity was reduced to 19% of normal liver values (5) . In each case tested the leukocyte urea cycle enzymes, other than the one showing the defect in liver, were well within normal limits.
The data indicate than an enzyme deficiency is demonstrable in peripheral blood in each of the conditions tested and that there is agreement between liver and blood results. DISCUSSION OTC, ASS + L, and arginase are also detectable in human sera (Table 3 ). This easily accessible tissue might then be the logical first choice for these enzyme studies. However, liver damage leads to leakage of enzymes into the serum. It is thus possible that a urea cycle enzyme deficiency might be overlooked in serum because of hepatic cell damage. In this regard it is of interest that our citrullinemic serum (Table 4 , patient I ) did show appropriate enzyme deficiency in two occasions, but the patient's clinical status by this time was stable. This is less likely to be true in the acute illness when such assays might be more useful.
The questioh of whether the observed leukocyte enzyme activity could arise from contamination from the serum was examined. In Table 3 the observed serum activities are converted to units per gram of serum protein for comparison with activities per gram of leukocyte protein. It is apparent that only a small fraction of the leukocyte activity could arise from serum, e g . , a maximum of 5% in the case of A R C even if the washing of the leukocytes were assumed to remove no serum protein.
The combined assay for ASS + L will not distinguish between a synthetase or lyase deficiency; however, the serum and urine amino acids are distinctively different in these two conditions. If more specific confirmation is required separate assays have been described for liver (4) . The combined assays reported here indicate both enzymes are present in leukocytes and in the one case tested a defect in the synthetase is detectable.
There are two carbamyl phosphate synthezases. C P S I, which uses ammonia as a nitrogen source and has an absolute requirement for N-acetylglutamate, provides the carbamylphosphate for the urea cycle. C P S 11, which utilizes glutamine preferentially or ammonia independently of N-acetylglutamate, provides the carbamylphosphate for pyrimidine synthesis (3). Assays which include N-acetylglutamate in the buffer-substrate are assumed to measure both C P S I and C P S 11. When N-acetylglutamate is absent the resulting activity must then be that of C P S 11. I t was found that in leukocytes C P S Il accounts for approximately 25-50% of the total C P S activity. In the case of patient 3, who has decreased liver C P S I but ample C P S I 1 (S), the leukocytes showed no activity of C P S I . amount comparable with the leukocyte extracts. A small amount Urea cycle enzyme activities are all detectable in circulating of synthetase activity was present but it all could be attributed to leukocytes, I n three diseases where directly tested in patients with C P S 11. W e were also unable to detect C P S in serum.
decreased liver enzyme activities, the leukocyte assays illustrated
In order perform a'1 four of the urea enzymes On theidentical decrease. Such studies may avoid the need for liver leukocytes a large blood sample (60 ml) is required. This is not a biopsy. serious liability because, of the five urea cycle enzyme defects accompanied by hyperammonemia, the last three in the cycle have easily recognized abnormalities in serum and urine amino acid concentrations. Therefore, with standard amino acid measurements the choice of enzymes t o be tested can be reduced.
In an effort to make these assays more sensitive, radioactive ornithine has been used in the measurement of C P S . In early trials activities similar to those reported above have been obtained with blood sample sizes reduced to 5 ml. ' CPS: carbamylphosphate synthetase; OTC: ornithine transcarbamylase; ASS + L: argininosuccinate synthetase and lyase; ARG: arginase. Extract Hormonal balance was studied in eight insulin-treated diabetic children who had excessive glycosuria. Glucose, growth hormone, and cortisol in plasma were determined every 0.5 hr for 48 hr. Total catecholamines and glucose were measured and tests for ketones done in 2-hourly collections of urine.
Intermittent hypoglycemia as Low as 20 mg/100 ml and swings of the blood sugar curve by 200-300 mg/100 ml within 2-4 hr were documented in most patients.
Peaks of growth hormone concentration in plasma (8-78 ng/ml) followed almost every sharp fall in blood glucose; these peaks were usually followed by abrupt rises of glucose and prolonged hyperglycemia.
Cortisol concentration was usually within the high normal range; there was no consistent relationship to the concentration of glucose.
Urinary excretion of catecholamines in most patients was between 1 and 6 ~l g l h r ; three patients excreted up to 8-23 pg/hr during short periods and up to 190 p g in 24 hr. The causes for the high excretion of catecholamines are unknown and may not have included hypoglycemia.
Speculation
Excessive production of growth hormone and possibly other hormonal antagonists of insulin may be provoked by hypoglycemia and other physiologic stresses in diabetic children. The resulting hyperglycemia may prompt the administration of increasing doses of insulin which, in turn, contribute to a vicious cycle of hypoglycemia alternating with hyperglycemia.
Hyperglycemia, excessive glycosuria, and ketonuria, alternating with occasional aglycosuria, may occur in diabetic patients who are treated with large amounts of insulin. Somogyi (50, 52) believed that excessive amounts of insulin resulting in hypoglycemia, often latent, were the cause of the hyperglycemia; he demonstrated that severely incapacitated patients suffering from unstable diabetes could be rehabilitated and their glycosuria could be reduced, apparently paradoxically, by gradual reduction of their insulin dose t a a fraction of the former one. Similar clinical observations were made by others (5. 44). who confirmed the benefits of reduction of the insulin dosage.
The pathogenesis of the "Sornogyi syndrome" was a matter of speculation before the development of laboratory methods which permitted investigation of hormonal balance. Somogyi (50, 51) suspected "hormones of the pituitary-adrenal system" to play a role, particularly epinephrine. A satisfactory hypothesis would have to explain both the rapid rise of blood glucose and the prolonged state of insulin resistance which have been demonstrated after hypoglycemia.
The purposes of our studies were ( I ) documentation of the existence of sequences of hypoglycemia causing hyperglycemia in diabetic children who have excessive glycosuria (such sequences have been reported by us (8) ) and (2) elucidation of the nature of hormonal responses to hypoglycemia. At least four hormones are now known to cause elevation of blood glucose: growth hormone, cortisol, epinephrine, and glucagon; some or all of-these may be produced in response to hypoglycemia.
MATERIALS AND METHODS
Eight children were studied. The clinical features of the course of the five boys and three girls and the details of the clinical study performed in the Clinical Research Center have been reported in an earlier communication (8) . Seven of these children had exhibited excessive glycosuria and occasional ketonuria which
